Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study.

Ther Adv Musculoskelet Dis · 2022 · PMC9772942 · PMID 36569491

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

just failed to reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

Only the General Health domain just failed to reach statistical significance in the IM neridronate group ( p = 0.06).

also in 203 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.